Clinical Trial Update: Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of Nephoxil® in subjects with end-stage renal disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia
• Kidney Failure Chronic
• Phosphorus Metabolism Disorders

Drugs mentioned

• NEPHOXIL

Snippet

Sponsor: Panion & BF Biotech Inc. | Conditions: Kidney Failure, Chronic, End-stage Renal Disease | Phase 4 | Status: COMPLETED